H35.07
Retinal telangiectasis
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinal telangiectasis is a condition characterized by abnormal dilation and formation of tiny blood vessels in the retina, the light-sensitive layer of tissue at the back of the eye. This disorder can lead to vision problems if left untreated, due to fluid leakage or bleeding from the affected vessels. The condition is often diagnosed through eye examinations and imaging techniques, and understanding its causes, symptoms, and available treatments is essential for managing the condition effectively.
Causes & Symptoms
Clinical Causes: Idiopathic origins, where the exact cause is unknown Associated with systemic conditions such as hypertension or diabetes mellitus Genetic predispositions can play a role in some cases Vascular abnormalities or congenital defects in blood vessel development Injury or trauma to the eye potentially contributing to vessel changes Inflammatory processes affecting retinal blood vessels
Key Symptoms: Blurred or distorted vision Presence of dark spots or floaters in the field of view Reduced visual acuity over time Shadows or shapes obscuring parts of the visual field Possible presence of retinal hemorrhages or exudates upon examination
Diagnostic & Treatment
Diagnosis Path: Diagnosis of retinal telangiectasis involves a comprehensive eye exam, including dilated fundus examination, where a healthcare professional observes the retina for abnormal vessels. Imaging techniques such as fluorescein angiography are crucial for identifying leakage and vascular abnormalities. Optical coherence tomography (OCT) provides detailed cross-sectional images of the retina, allowing assessment of retinal thickness and fluid accumulation. These diagnostic tools help differentiate retinal telangiectasis from other retinal conditions and guide appropriate management.
Treatment Protocols: Treatment options focus on preventing or reducing vision loss by addressing abnormal blood vessels and leakage. Common approaches include: - Laser photocoagulation: Using laser energy to seal leaking vessels and prevent bleeding. - Anti-VEGF (vascular endothelial growth factor) injections: Medications that inhibit abnormal blood vessel growth and decrease fluid leakage. - Observation: In cases where the condition is mild and not affecting vision, regular monitoring may be recommended. - Management of underlying systemic conditions: Controlling blood pressure or blood sugar levels can help slow progression. The specific treatment plan depends on the severity of the condition, the presence of hemorrhages or exudates, and the patient’s overall health status. Regular follow-ups with an eye care professional are vital for monitoring disease progression and adjusting treatments as needed.
Clinical Advice & FAQs
Billing Guidance
Is H35.07 a billable ICD-10 code?
Yes, H35.07 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.07?
Clinical documentation must specify the nature of Retinal telangiectasis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference